THE PHILIP S. CHEN, JR., PH.D. DISTINGUISHED LECTURE ON INNOVATION AND TECHNOLOGY TRANSFER

 

The Philip S. Chen, Jr., Ph.D. Distinguished Lecture on Innovation and Technology Transfer was established in 2006 by the NIH Deputy Director for Intramural Research and the NIH Office of Technology Transfer on the occasion of Dr. Chen’s retirement after over 41 years of service to the NIH. The lectureship honors Dr. Chen’s remarkable, diverse, and creative contributions to the NIH, especially to its Intramural Research Program and to the field of technology transfer.
 
About Philip S. Chen, Jr.
Philip S. Chen, Jr., Ph.D.
After receiving his Ph.D. in Pharmacology from the University of Rochester, Dr. Chen had a distinguished research career, including primary authorship in one of the most cited publications of all time, describing an analytical technique for determination of inorganic phosphorus. Dr. Chen served under eight NIH Directors from 1956 to 1959 and from 1967 to 2005. He held positions in the National Heart Institute, the Division of Research Grants, the National Institute of General Medical Sciences, and the Office of the Director, NIH, that ranged from that of research investigator to Associate Director for Intramural Affairs; he also served as Acting Deputy Directory for Science from 1982-1983. As a science administrator he championed novel pay and personnel systems for scientific researchers, programs for the training of foreign scientists at NIH, novel endeavors such as artic research, and many other areas.
 
 
In 1986 Dr. Chen established the NIH Office of Technology Transfer to implement the provisions of the Federal Technology Transfer Act. He formulated the guiding principles upon which technology transfer functions today, including the creation of the Cooperative Research and Development Agreement, known as the CRADA. Above all, Dr. Chen offered NIHers wise, trusted, and compassionate counsel in diverse areas; this earned him the respect, admiration, and gratitude of the scientific and administrative communities at the NIH.
 
Past Lectures
 
 
12th Annual Philip S. Chen, Jr., Ph.D. Distinguished Lecture on Innovation and Technology Transfer
Friday, November 17, 2017
Steven A. Rosenberg, M.D., Ph.D.

CELLS AS ANTI-CANCER DRUGS: ENTERING MAINSTREAM ONCOLOGY

Steven A. Rosenberg, M.D., Ph.D.
Chief, Surgery Branch and Senior Investigator
National Cancer Institute

https://videocast.nih.gov/launch.asp?23596

   
   
11th Annual Philip S. Chen, Jr., Ph.D. Distinguished Lecture on Innovation and Technology Transfer
Friday, October 14, 2016
John J. O'Shea, M.D.
CYTOKINE SIGNALING: GENES, GENOMES AND DRUGS
 
John J. O'Shea, M.D. 
Scientific Director and Senior Investigator 
National Institute of Arthritis and Musculoskeletal and Skin Diseases
 
   
   
10th Annual Philip S. Chen, Jr., Ph.D. Distinguished Lecture on Innovation and Technology Transfer
Friday, October 23, 2015
Robert M. Kotin, Ph.D.
UNEXPECTED RESULTS FROM UNCONVENTIONAL APPROACHES TO ADENO-ASSOCIATED VIRUS RESEARCH
 
Robert M. Kotin, Ph.D.
Senior Investigator (1999–2014) at the National Heart, Lung and Blood Institute; 
Vice President of Voyager Therapeutics (2014-2016); 
Scientific Founder and Head of Discovery at Generation Bio, and Adjunct Professor at the Gene Therapy Center of the University of Massachusetts Medical School in Worcester
 
   
   
9th Annual Philip S. Chen, Jr., Ph.D. Distinguished Lecture on Innovation and Technology Transfer
Friday, October 3, 2014
Kenneth A. Jacobson, Ph.D.
PURINE RECEPTOR DRUGS: FUTURE TREATMENT FOR CHRONIC DISEASES?
 
Kenneth A. Jacobson, Ph.D.
Chief, Laboratory of Bioorganic Chemistry & Molecular Recognition Section
National Institute of Diabetes & Digestive & Kidney Diseases
 
   
   
8th Annual Philip S. Chen, Jr., Ph.D. Distinguished Lecture on Innovation and Technology Transfer
Friday, November 22, 2013

Clifton E. Barry III, Ph.D.Carol A. Nacy, Ph.D.

TB: IT TAKES MORE THAN A VILLAGE TO RAISE A REMEDY  
 
Clifton E. Barry III, Ph.D.
Chief, Tuberculosis Research Section
National Institute of Allergy and Infectious Diseases
 
Carol A. Nacy, Ph.D.
Co-Founder and CEO
Sequella, Inc.
 
   
7th Annual Philip S. Chen, Jr., Ph.D. Distinguished Lecture on Innovation and Technology Transfer
Thursday, November 15, 2012
Hynda K. Kleinman, Ph.D.
A MULTIFUNCTIONAL BASEMENT MATRIX FOR NORMAL, CANCER, AND STEM CELLS: THE BME/MATRIGEL STORY 
 
Hynda K. Kleinman, Ph.D.
former Senior Investigator
National Institute of Dental and Craniofacial Research
 
   
   
6th Annual Philip S. Chen, Jr., Ph.D. Distinguished Lecture on Innovation and Technology Transfer
Friday, December 9, 2011
Ira Pastan, M.D.
TREATMENT OF CANCER WITH RECOMBINANT IMMUNOTOXINS: FROM TECHNOLOGY TRANSFER TO THE PATIENT
 
Ira Pastan, M.D.
Co-Chief, Laboratory of Molecular Biology
Head, Molecular Biology Section
National Cancer Institute
 
   
   
5th Annual Philip S. Chen, Jr., Ph.D. Distinguished Lecture on Innovation and Technology Transfer
November 5, 2010
Robert C. Gallo, M.D.
HUMAN RETROVIRUSES: PERSPECTIVES FROM THE PAST, PROSPECTS FOR THE FUTURE
 
Robert C. Gallo, M.D.
The Homer & Martha Gudelsky Distinguished Professor in Medicine, and 
Director, Institute of Human Virology 
at the University of Maryland School of Medicine
 
   
   
4th Annual Philip S. Chen, Jr., Ph.D. Distinguished Lecture on Innovation and Technology Transfer
November 13, 2009

Harvey J. Alter, M.D.Robert H. Purcell, M.D.

VIRAL HEPATITIS AND THE NIH: A JAUNDICED VIEW OF HISTORY
 
Harvey J. Alter, M.D.
Chief, Infectious Disease
Department of Transfusion Medicine
NIH Clinical Center
 
Robert H. Purcell, M.D.
Co-Chief, Laboratory of Infectious Diseases
National Institute of Allergy and Infectious Diseases
 
   
   
3rd Annual Philip S. Chen, Jr., Ph.D. Distinguished Lecture on Innovation and Technology Transfer
September 18, 2008
Robert S. Balaban, Ph.D.
INNOVATION IN THE IMAGING SCIENCES AT THE NATIONAL INSTITUTES OF HEALTH
 
Robert S. Balaban, Ph.D.
Director, Division of Intramural Research
National Heart, Lung, and Blood Institute
 
   
   
2nd Annual Philip S. Chen, Jr., Ph.D. Distinguished Lecture on Innovation and Technology Transfer
Friday, January 26, 2007
Douglas R. Lowy, M.D.
THE SCIENCE, TECHNOLOGY AND PROMISE OF PREVENTIVE HPV VACCINES 
 
Douglas R. Lowy, M.D.
Deputy Director, Center for Cancer Research
Chief, Laboratory of Cellular Oncology
National Cancer Institute
 
   
   
First Annual Philip S. Chen, Jr., Ph.D. Distinguished Lecture on Innovation and Technology Transfer
Friday, January 20, 2006
Maria Freire, Ph.D.
INNOVATION AND COLLABORATION: REVOLUTIONIZING TB THERAPY
 
Maria Freire, Ph.D.
CEO & President 
Global Alliance for TB Drug Development